<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><generator uri="https://jekyllrb.com/" version="3.10.0">Jekyll</generator><link href="https://peptide-mastery.com/blog/feed.xml" rel="self" type="application/atom+xml" /><link href="https://peptide-mastery.com/" rel="alternate" type="text/html" hreflang="en" /><updated>2026-11-13T18:54:36-05:00</updated><id>https://peptide-mastery.com/blog/feed.xml</id><title type="html">Reality Supps Research Notes</title><subtitle>Factual notes on research peptides for qualified researchers. Certificates, storage, compound primers, supplier due diligence. Research use only.</subtitle><author><name>Reality Supps Research Desk</name></author><entry><title type="html">Choosing a research peptide supplier after the 2025–2026 shutdowns</title><link href="https://peptide-mastery.com/blog/choosing-a-research-peptide-supplier/" rel="alternate" type="text/html" title="Choosing a research peptide supplier after the 2025–2026 shutdowns" /><published>2026-10-06T00:00:00-04:00</published><updated>2026-10-06T00:00:00-04:00</updated><id>https://peptide-mastery.com/blog/choosing-a-research-peptide-supplier</id><content type="html" xml:base="https://peptide-mastery.com/blog/choosing-a-research-peptide-supplier/"><![CDATA[<p>The research-peptide supply market reorganized itself between mid-2025 and late 2026. Peptide Sciences, for years the largest United States vendor by traffic, discontinued sales on March 6, 2026. Amino Asylum went offline after a federal inspection in June 2025. Paradigm Peptides’ owners pleaded guilty in December 2025 and were sentenced the following July. Smaller vendors closed through 2026 as payment processors withdrew.</p>

<p>For a researcher the practical question is how to evaluate the suppliers that remain. These seven checks take about fifteen minutes.</p>

<h2 id="1-certificates-per-lot-from-a-named-laboratory">1. Certificates per lot, from a named laboratory</h2>

<p>Ask for the certificate for the specific lot being sold, not a representative certificate. It should name the laboratory, state the method (HPLC and mass spectrometry), carry a recent date, and be published as issued. A supplier that offers certificates “on request” is asking you to trust rather than verify.</p>

<h2 id="2-independent-blind-testing">2. Independent blind testing</h2>

<p>A growing number of researchers rely on third-party programs that purchase vials anonymously and test them. A supplier whose lots have been blind-tested, with the results public, has passed a check it could not influence. A supplier with no blind-test history is unproven, not necessarily bad.</p>

<h2 id="3-card-payment-accepted">3. Card payment accepted</h2>

<p>Card acceptance is a proxy for underwriting. A merchant account survives only if a processor has reviewed the business and its chargeback history. Suppliers that accept only cryptocurrency or peer-to-peer apps have usually lost that review, and the buyer carries all of the risk on an irreversible payment.</p>

<h2 id="4-a-legal-entity-with-an-address-and-a-phone-number">4. A legal entity with an address and a phone number</h2>

<p>Look at the footer. A supplier that names its legal entity, a physical address and a working phone number can be held to its terms. One that offers a contact form and nothing else cannot.</p>

<h2 id="5-stated-shipping-and-returns-terms">5. Stated shipping and returns terms</h2>

<p>Specific terms (“orders before 2 PM Eastern ship the same business day”; “sealed vials returnable within seven days”) indicate an operation that fulfills orders routinely. Vague terms indicate the opposite.</p>

<h2 id="6-copy-that-describes-research-not-results">6. Copy that describes research, not results</h2>

<p>Read two product pages. A supplier operating as a research supplier describes structure, origin and the models studied, and cites sources. One that describes results in people, offers dosing guidance, or sells administration supplies alongside compounds is advertising something other than research use, and has been the target of the regulatory actions of the last two years.</p>

<h2 id="7-time-in-operation">7. Time in operation</h2>

<p>Twelve months of continuous operation after mid-2025 is now a meaningful signal. The vendors that closed did so for identifiable reasons: regulatory correspondence they did not answer, product that was not what the label said, or processors that withdrew. A supplier that has stayed open through that period has, at minimum, avoided those three.</p>

<h2 id="a-short-checklist">A short checklist</h2>

<table>
  <thead>
    <tr>
      <th>Check</th>
      <th>Pass</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Lot-specific certificate from a named lab, HPLC + MS</td>
      <td>Yes / No</td>
    </tr>
    <tr>
      <td>Public blind-test results</td>
      <td>Yes / No / None yet</td>
    </tr>
    <tr>
      <td>Card payment accepted</td>
      <td>Yes / No</td>
    </tr>
    <tr>
      <td>Entity, address, phone in footer</td>
      <td>Yes / No</td>
    </tr>
    <tr>
      <td>Specific shipping and returns terms</td>
      <td>Yes / No</td>
    </tr>
    <tr>
      <td>Research-only copy, sourced, no dosing</td>
      <td>Yes / No</td>
    </tr>
    <tr>
      <td>Twelve months of operation</td>
      <td>Yes / No</td>
    </tr>
  </tbody>
</table>

<p>Five or more passes is a supplier worth trying with a small order. Fewer than four is a supplier to avoid regardless of price.</p>

<h2 id="references">References</h2>

<ul>
  <li>U.S. Food and Drug Administration, Warning Letters to research-peptide sellers, December 2024 through August 2026 (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters).</li>
  <li>U.S. Department of Justice, Northern District of Indiana, United States v. Kawa and Stechkober (plea December 2025; sentencing July 30, 2026).</li>
  <li>Eli Lilly and Company, press release on enforcement referrals and litigation concerning unapproved retatrutide sellers (August 12, 2026).</li>
</ul>]]></content><author><name>Reality Supps Research Desk</name></author><category term="Due diligence" /><summary type="html"><![CDATA[Peptide Sciences closed in March 2026 and at least seven other vendors went dark in eighteen months. The seven checks a researcher should run on any supplier before ordering.]]></summary></entry><entry><title type="html">How to read a peptide certificate of analysis</title><link href="https://peptide-mastery.com/blog/how-to-read-a-peptide-certificate-of-analysis/" rel="alternate" type="text/html" title="How to read a peptide certificate of analysis" /><published>2026-10-06T00:00:00-04:00</published><updated>2026-10-06T00:00:00-04:00</updated><id>https://peptide-mastery.com/blog/how-to-read-a-peptide-certificate-of-analysis</id><content type="html" xml:base="https://peptide-mastery.com/blog/how-to-read-a-peptide-certificate-of-analysis/"><![CDATA[<p>A certificate of analysis (COA) is the document a testing laboratory issues for one production lot of a compound. For a research peptide it is the only objective evidence a buyer has about what is in the vial. Reading one takes two minutes once you know where to look.</p>

<h2 id="what-a-certificate-must-contain">What a certificate must contain</h2>

<p>A usable certificate names five things. If any are missing, treat the document as marketing, not analysis.</p>

<table>
  <thead>
    <tr>
      <th>Field</th>
      <th>What it tells you</th>
      <th>What to check</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Laboratory</td>
      <td>Who ran the test</td>
      <td>A named, independent lab with a street address. In-house “QC” is not independent.</td>
    </tr>
    <tr>
      <td>Lot or batch number</td>
      <td>Which production run was tested</td>
      <td>It must match the number printed on the vial label, character for character.</td>
    </tr>
    <tr>
      <td>Test date</td>
      <td>How recent the analysis is</td>
      <td>Within the last few months for an active lot. A certificate from a lot that sold out a year ago says nothing about the vial in hand.</td>
    </tr>
    <tr>
      <td>Method</td>
      <td>How purity and identity were measured</td>
      <td>HPLC for purity, mass spectrometry for identity. One without the other is half an answer.</td>
    </tr>
    <tr>
      <td>Result</td>
      <td>The measured figure</td>
      <td>A number, such as 98.6 percent, not a range and not a threshold like “≥98 percent” copied from a label.</td>
    </tr>
  </tbody>
</table>

<h2 id="purity-and-identity-are-different-tests">Purity and identity are different tests</h2>

<p>Purity, measured by high-performance liquid chromatography (HPLC), is the share of the sample that elutes as the main peak. A figure of 98 percent means 2 percent of the material is something else: truncated sequences, deletion products or residual reagents from synthesis.</p>

<p>Identity, measured by mass spectrometry (MS), confirms that the main peak has the molecular weight of the compound named on the label. A sample can be 99 percent pure and still be the wrong molecule. A certificate that reports purity without a mass result has not confirmed identity.</p>

<p>Some laboratories add a third panel: net content (how many milligrams are actually in the vial), endotoxin and sterility. These are more expensive and less common. Their absence is not a red flag; their presence is a good sign.</p>

<h2 id="reading-the-chromatogram">Reading the chromatogram</h2>

<p>Most certificates include the HPLC trace. Three features matter:</p>

<ol>
  <li><strong>One dominant peak.</strong> The target compound should be a single tall peak. Several peaks of similar height indicate a mixture.</li>
  <li><strong>Retention time.</strong> The time at which the main peak elutes should be consistent across lots of the same compound from the same lab. A shifted retention time with the same purity figure deserves a question.</li>
  <li><strong>Baseline.</strong> A noisy or rising baseline can hide small impurity peaks. Clean certificates show a flat baseline on either side of the main peak.</li>
</ol>

<h2 id="four-checks-before-trusting-a-certificate">Four checks before trusting a certificate</h2>

<ol>
  <li>The lot on the certificate is the lot on the vial.</li>
  <li>The laboratory is named and can be looked up.</li>
  <li>The method is stated and includes both HPLC and MS.</li>
  <li>The certificate is published as issued, with the lab’s own formatting, not retyped into the supplier’s template.</li>
</ol>

<p>The fourth check matters more than it looks. Altered or fabricated certificates were a central fact in the only research-peptide case to date that ended in a prison sentence (United States v. Kawa, N.D. Indiana, sentenced July 2026). A supplier that publishes certificates unedited is taking on accountability for them.</p>

<h2 id="how-reality-supps-publishes-certificates">How Reality Supps publishes certificates</h2>

<p>Each lot in the catalog links to its certificate as issued by the testing laboratory. The lot number printed on the vial label can be entered in the lot lookup on the <a href="/#testing">testing page</a> to open the same document.</p>

<h2 id="references">References</h2>

<ul>
  <li>U.S. Pharmacopeia, General Chapter ⟨621⟩ Chromatography.</li>
  <li>International Council for Harmonisation, Q2(R2) Validation of Analytical Procedures (2023).</li>
  <li>U.S. Department of Justice, Northern District of Indiana, press release on sentencing in United States v. Kawa (July 30, 2026).</li>
</ul>]]></content><author><name>Reality Supps Research Desk</name></author><category term="Certificates" /><summary type="html"><![CDATA[What the lot number, test method, purity figure and retention time on a COA actually mean, and the four checks that separate a real certificate from a decorative one.]]></summary></entry><entry><title type="html">Lyophilized peptides: storage and stability</title><link href="https://peptide-mastery.com/blog/lyophilized-peptide-storage-and-stability/" rel="alternate" type="text/html" title="Lyophilized peptides: storage and stability" /><published>2026-10-06T00:00:00-04:00</published><updated>2026-10-06T00:00:00-04:00</updated><id>https://peptide-mastery.com/blog/lyophilized-peptide-storage-and-stability</id><content type="html" xml:base="https://peptide-mastery.com/blog/lyophilized-peptide-storage-and-stability/"><![CDATA[<p>Almost every research peptide is supplied as a lyophilized powder: the compound is dissolved, frozen, and the water is removed under vacuum, leaving a dry cake in a sealed vial. The format exists for one reason. Peptides in solution degrade; peptides as dry powder, kept cold and dark, do not degrade quickly.</p>

<h2 id="what-degrades-a-peptide">What degrades a peptide</h2>

<p>Four processes account for most loss of purity in storage.</p>

<ul>
  <li><strong>Hydrolysis.</strong> Water cleaves peptide bonds, particularly at aspartic acid residues. Lyophilization removes the water; moisture that re-enters a vial through a compromised seal restarts the process.</li>
  <li><strong>Oxidation.</strong> Methionine, cysteine and tryptophan residues oxidize on contact with air. Vials are typically sealed under nitrogen or argon to limit this.</li>
  <li><strong>Deamidation.</strong> Asparagine and glutamine residues convert to acidic forms over time. The rate rises with temperature and with pH in solution.</li>
  <li><strong>Aggregation.</strong> Some sequences self-associate when concentrated or warmed, producing material that no longer elutes as a single peak.</li>
</ul>

<p>Every one of these is slower at lower temperature, which is why the storage guidance for the sealed vial is simple.</p>

<h2 id="storage-of-the-sealed-vial">Storage of the sealed vial</h2>

<table>
  <thead>
    <tr>
      <th>Condition</th>
      <th>Guidance</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Temperature</td>
      <td>−20 °C for long-term storage. 2 to 8 °C is acceptable for short periods.</td>
    </tr>
    <tr>
      <td>Light</td>
      <td>Protect from light. Tryptophan- and tyrosine-containing sequences are light-sensitive.</td>
    </tr>
    <tr>
      <td>Humidity</td>
      <td>Keep the crimp seal intact. Do not open a cold vial until it has reached room temperature, or condensation will form on the cake.</td>
    </tr>
    <tr>
      <td>Handling</td>
      <td>Avoid repeated temperature cycling. Move a vial from freezer to bench once, not daily.</td>
    </tr>
  </tbody>
</table>

<p>Under these conditions most lyophilized peptides hold specification for twelve months or longer. The stability figure for a specific lot, where the laboratory has measured it, is listed on the lot’s certificate of analysis.</p>

<h2 id="shipping">Shipping</h2>

<p>Lyophilized powder tolerates the few days of ambient temperature a shipment takes. Cold-chain shipping is not required for the dry form and is usually marketing. What matters is that the vial arrives sealed, with the crimp intact and the cake dry and intact at the bottom of the vial.</p>

<h2 id="signs-a-vial-is-out-of-specification">Signs a vial is out of specification</h2>

<ul>
  <li>The cake has collapsed into a glassy film or a wet smear.</li>
  <li>The cake has discolored (most peptides are white to off-white).</li>
  <li>The crimp or stopper is loose, or the vial was received warm after a long transit.</li>
</ul>

<p>A vial showing any of these should not be used for research and can be returned under the sealed-vial policy on the <a href="/#ordering">ordering page</a>.</p>

<h2 id="references">References</h2>

<ul>
  <li>Manning, M. C., et al. “Stability of protein pharmaceuticals: an update.” <em>Pharmaceutical Research</em> 27 (2010): 544–575.</li>
  <li>Lai, M. C., and Topp, E. M. “Solid-state chemical stability of proteins and peptides.” <em>Journal of Pharmaceutical Sciences</em> 88 (1999): 489–500.</li>
</ul>]]></content><author><name>Reality Supps Research Desk</name></author><category term="Handling" /><summary type="html"><![CDATA[Why research peptides ship as freeze-dried powder, what degrades them, and the storage conditions that keep a sealed vial within specification.]]></summary></entry><entry><title type="html">What “research use only” means in 2026</title><link href="https://peptide-mastery.com/blog/research-use-only-what-it-means-in-2026/" rel="alternate" type="text/html" title="What “research use only” means in 2026" /><published>2026-10-06T00:00:00-04:00</published><updated>2026-10-06T00:00:00-04:00</updated><id>https://peptide-mastery.com/blog/research-use-only-what-it-means-in-2026</id><content type="html" xml:base="https://peptide-mastery.com/blog/research-use-only-what-it-means-in-2026/"><![CDATA[<p>Every product in this catalog carries the words “Research Use Only.” The phrase has a specific meaning, and in the current enforcement climate it is worth understanding exactly what it does and does not do.</p>

<h2 id="the-designation">The designation</h2>

<p>Research use only (RUO) describes a product supplied for in-vitro laboratory research: work done in cell culture, in biochemical assays, or in analytical instruments. It is not a product category created by statute. It is a statement of intended use made by the supplier, and the supplier’s conduct has to match it.</p>

<p>Under United States law a product becomes a drug when it is intended to diagnose, treat, mitigate or prevent disease, or to affect the structure or function of the body. Intent is judged from the circumstances surrounding distribution, including how a product is described, what is sold alongside it, and who it is sold to. The label is one piece of that evidence, not the whole of it.</p>

<h2 id="what-follows-from-that">What follows from that</h2>

<p>Because intent is read from the whole picture, a research supplier that takes the designation seriously behaves in recognizable ways:</p>

<ul>
  <li>It describes compounds by their chemistry and by the models in which they have been studied, not by outcomes in people.</li>
  <li>It publishes no dosing, administration or protocol information, and does not sell the supplies used to administer compounds.</li>
  <li>It does not name approved drugs as equivalents.</li>
  <li>It verifies that purchasers are adults and qualified researchers, and refuses orders that indicate another intended use.</li>
  <li>It publishes independent analytical data for every lot, because the research use of a compound depends on knowing what it is.</li>
</ul>

<p>The Food and Drug Administration’s correspondence with research-peptide sellers since late 2024 has cited the absence of each of these practices as evidence of intended human use, regardless of what the label said. The designation protects a supplier that operates as a research supplier. It protects nothing else.</p>

<h2 id="who-may-purchase">Who may purchase</h2>

<p>Reality Supps sells to qualified researchers and research organizations who are at least 21 years of age. Qualified means a person or institution engaged in laboratory research with the facilities to conduct it. At checkout each purchaser confirms this, and a first order requires a signed research-use agreement on file.</p>

<p>An order, a message or a social-media post indicating that a product is intended for a person or an animal is grounds for refusal and refund. This is not a formality. It is the mechanism by which the designation stays true.</p>

<h2 id="what-the-purchaser-agrees-to">What the purchaser agrees to</h2>

<p>The research-use agreement and the Terms of Sale cover five points:</p>

<ol>
  <li>Products are not for human or animal consumption, application, injection or any form of bodily administration.</li>
  <li>Products are not foods, drugs, cosmetics, medical devices or dietary supplements.</li>
  <li>The purchaser is a qualified researcher or is purchasing on behalf of a research organization.</li>
  <li>Products will not be combined, mixed or otherwise prepared for administration to any human or animal.</li>
  <li>The purchaser indemnifies the supplier against misuse.</li>
</ol>

<h2 id="why-there-is-no-dosing-information-here">Why there is no dosing information here</h2>

<p>Readers sometimes ask why a research supplier publishes compound chemistry and model summaries but nothing about amounts, frequency or route. The answer is the paragraph above on intent. Dosing information describes administration to a subject. A research supplier has no basis to provide it and every reason not to.</p>

<h2 id="references">References</h2>

<ul>
  <li>Federal Food, Drug, and Cosmetic Act, section 201(g)(1) (definition of drug).</li>
  <li>21 C.F.R. § 201.128 (meaning of “intended uses”).</li>
  <li>U.S. Food and Drug Administration, “FDA’s concerns with unapproved GLP-1 drugs used for weight loss,” updated October 2026.</li>
</ul>]]></content><author><name>Reality Supps Research Desk</name></author><category term="Access" /><summary type="html"><![CDATA[The legal meaning of the research-use-only designation, who may purchase under it, what the attestation covers, and why a research supplier publishes no dosing information.]]></summary></entry><entry><title type="html">What is BPC-157? Structure, origin and the research models that have examined it</title><link href="https://peptide-mastery.com/blog/what-is-bpc-157/" rel="alternate" type="text/html" title="What is BPC-157? Structure, origin and the research models that have examined it" /><published>2026-10-06T00:00:00-04:00</published><updated>2026-10-06T00:00:00-04:00</updated><id>https://peptide-mastery.com/blog/what-is-bpc-157</id><content type="html" xml:base="https://peptide-mastery.com/blog/what-is-bpc-157/"><![CDATA[<p>BPC-157 is the most frequently cited compound in the research-peptide literature and the most frequently misdescribed. This note covers what it is and what has actually been studied, without the claims that usually accompany it.</p>

<h2 id="structure-and-origin">Structure and origin</h2>

<p>BPC-157 is a synthetic peptide of fifteen amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and a molecular weight of about 1,419 daltons. The “BPC” stands for Body Protection Compound, the name given by a group at the University of Zagreb to a protein they isolated from human gastric juice in the early 1990s. BPC-157 is a fragment of that protein, chosen because it was the shortest segment that retained activity in the group’s assays.</p>

<p>The compound is made by solid-phase peptide synthesis rather than extracted from tissue. Two forms appear in the literature: the acetate salt and an arginate salt described as more stable in solution. Research suppliers typically list the acetate form.</p>

<h2 id="what-the-research-has-examined">What the research has examined</h2>

<p>The published work is dominated by one laboratory group and is almost entirely in cell culture and rodent models. Three lines of investigation recur.</p>

<p><strong>Tendon and muscle injury models.</strong> Chang and colleagues (2011) studied the peptide in cultured tendon fibroblasts and reported effects on cell outgrowth, survival and migration, with changes in growth-hormone receptor expression. Rodent studies from the Zagreb group have used transected Achilles tendon, crushed quadriceps and similar injury models.</p>

<p><strong>Vascular signaling.</strong> Several papers describe interaction with the nitric-oxide system and with VEGFR2 signaling in cell and animal models, which the authors connect to angiogenesis in injured tissue.</p>

<p><strong>Gastrointestinal models.</strong> The earliest studies, consistent with the compound’s origin, used rodent models of gastric and intestinal lesions. Later papers extended the same approach to a brain–gut axis framing.</p>

<p>What the literature does not contain is as important as what it does. There are no published controlled human trials of BPC-157. One Phase 1 study of an oral formulation is registered but unpublished. The compound is not approved by any regulator for any use, and the World Anti-Doping Agency lists it as prohibited in sport.</p>

<h2 id="how-to-evaluate-a-bpc-157-lot">How to evaluate a BPC-157 lot</h2>

<p>Because the sequence is short and well characterized, identity by mass spectrometry is straightforward: the main peak should correspond to about 1,419 Da. Purity by HPLC above 98 percent is routine for a competent synthesis. The common failure is not purity but net content, where a vial labeled 10 mg contains materially less, so a certificate that reports fill weight is worth more than one that reports purity alone.</p>

<h2 id="references">References</h2>

<ul>
  <li>Chang, C. H., et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” <em>Journal of Applied Physiology</em> 110 (2011): 774–780.</li>
  <li>Seiwerth, S., et al. “BPC 157 and standard angiogenic growth factors.” <em>Current Pharmaceutical Design</em> 24 (2018): 1972–1989.</li>
  <li>Sikiric, P., et al. “Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications.” <em>Current Neuropharmacology</em> 14 (2016): 857–865.</li>
  <li>World Anti-Doping Agency, Prohibited List (2026), section S0.</li>
</ul>]]></content><author><name>Reality Supps Research Desk</name></author><category term="Compound primer" /><summary type="html"><![CDATA[A primer on the pentadecapeptide BPC-157: where the sequence comes from, how it is made, and what the in-vitro and animal literature has studied.]]></summary></entry></feed>